SCA Pharmaceuticals of Little Rock, which makes sterile pharmaceuticals for hospital pharmacies and health care facilities throughout the country, announced Tuesday that it will expand its operations in Little Rock.
The company plans to invest more than $10 million and double its Little Rock workforce of 180 people. And it said it will renovate an existing 42,000-SF facility at the Clinton National Airport and build another 20,000-SF facility adjacent to it.
The company announced last week plans for a 40% expansion of its facility in Windsor, Connecticut.
“We are very pleased that, as we continue our geographical expansions in both Arkansas and Connecticut, we can partner with the Arkansas Economic Development Commission and the Little Rock Municipal Airport Commission to solidify and expand the operations of our legacy operations,” CEO Milton Boyer said in a news release. “Little Rock has been the foundation that has allowed for our other expansion projects, and this project will bolster that foundation for years to come.”
SCA, founded in Little Rock in 2010, said it has experienced significant growth over the past five years and has emerged as a leading manufacturer of compounded pharmaceuticals.
“Arkansas is committed to nurturing its homegrown companies from seed stage upward,” Gov. Asa Hutchinson said in the release. “We are proud to see the success that SCA Pharma is experiencing and look forward to the products and services being developed here in central Arkansas that will positively impact the lives of people around the country.”
The company has qualified for a $2 million package of state incentives: five years of the Create Rebate, an annual cash rebate based on the number of jobs added by a company, worth $1.2 million; the Tax Back program, which provides sales tax refunds on building materials, taxable machinery and equipment associated with the project, worth $63,276; and $750,000 from the governor’s Quick Action Closing Fund $750,000.
SCA was founded by Dr. Gene Graves, who retired in 2017.